How resilient were we in 2021? Results of a LinkedIn Survey including biomedical and pharmaceutical professionals using the Benatti Resiliency Model

我们在2021年的韧性如何?一项LinkedIn调查的结果显示,生物医学和制药行业的专业人士运用了贝纳蒂韧性模型进行评估。

阅读:1

Abstract

Enhancing resiliency should elevate innovation and efficiency in biomedical research and development (R&D); however, compared with other professions, data on practice of resilience is lacking. Using the Benatti Resiliency Model (5 anchors: Well-Being, Self-Awareness, Brand, Connection, and Innovation), we surveyed professionals, including those in biomedical and pharmaceutical R&D. A structured LinkedIn questionnaire (March 16-May 23, 2021), surveyed each model anchor using five categories. One hundred fifty-eight participants (~6% student/trainee, 18%, 27%, and 49% in 1-5, 5-15 or >15 years post-terminal degree) took the survey (90 in biomedical and pharmaceutical R&D). Over 50% chose "always"/"often" across questions, except external influence or engagement. The question with one of the lowest "always" scores (~15%) was "I get feedback on my influence and impact in my career" in Brand, highlighting areas for leadership development and coaching. In the anchor of Well-being, nutrition and stress management also received some lowest "always" scores (~15% for both). Connection and Innovation scores trended slightly higher in biomedical and pharmaceutical R&D. No students/trainees chose "always" in Brand, indicating evolution of brand maturity over time. Self- and survey-assessed resiliency scores were associated (r(s)  = 0.37, p < 0.0001). Our survey yielded actionable insights on Resilience, including "best practices" through an open-ended question for one thing most useful to boost resilience in the survey and is the first application of the Benatti Model for crowdsourced research.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。